Back to Search Start Over

Cytokine-enhanced cytolytic activity of exosomes from NK Cells.

Authors :
Enomoto Y
Li P
Jenkins LM
Anastasakis D
Lyons GC
Hafner M
Leonard WJ
Source :
Cancer gene therapy [Cancer Gene Ther] 2022 Jun; Vol. 29 (6), pp. 734-749. Date of Electronic Publication: 2021 Jul 27.
Publication Year :
2022

Abstract

Natural killer (NK) cells play key roles in immune surveillance against tumors and viral infection. NK cells distinguish abnormal cells from healthy cells by cell-cell interaction with cell surface proteins and then attack target cells via multiple mechanisms. In addition, extracellular vesicles (EVs) derived from NK cells (NK-EVs), including exosomes, possess cytotoxic capacity against tumor cells, but their characteristics and regulation by cytokines remain unknown. Here, we report that EVs derived from human NK-92 cells stimulated with IL-15 + IL-21 show enhanced cytotoxic capacity against tumor cells. Major cytolytic granules, granzyme B and granzyme H, are enriched by IL-15 + IL-21 stimulation in NK-EVs; however, knockout experiments reveal those cytolytic granules are independent of enhanced cytotoxic capacity. To find out the key molecules, mass spectrometry analyses were performed with different cytokine conditions, no cytokine, IL-15, IL-21, or IL-15 + IL-21. We then found that CD226 (DNAM-1) on NK-EVs is enriched by IL-15 + IL-21 stimulation and that blocking antibodies against CD226 reduced the cytolytic activity of NK-EVs. We also show NK-EVs are taken up by target cells via macropinocytosis. Collectively, our findings elucidate the novel properties of NK-EVs and the mechanism of their incorporation into target cells.<br /> (© 2021. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2021.)

Details

Language :
English
ISSN :
1476-5500
Volume :
29
Issue :
6
Database :
MEDLINE
Journal :
Cancer gene therapy
Publication Type :
Academic Journal
Accession number :
34316033
Full Text :
https://doi.org/10.1038/s41417-021-00352-2